Evidence map›Paper›PMID 21894544›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2012

Myocardial perfusion scintigraphy in Europe 2007: a survey of the European Council of Nuclear Cardiology.

Eliana Reyes, Susanna Wiener, S Richard Underwood, European Council of Nuclear Cardiology

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Single-photon cardiac imaging in patients with cardiac implantable electrical devices.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2022
    Review
  5. Article
  6. Reducing radiation to patients and improving image quality in a real-world nuclear cardiology laboratory.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2017
    Review
  7. Nuclear cardiology practice in Spain.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2017
    Article
  8. Myocardial perfusion SPECT 2015 in Germany. Results of the 7Nuklearmedizin. Nuclear medicine · 2017
    Article
  9. Combined supine and prone imaging acquisition in cardiac SPECT: A turn for the better.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2016
    Article
  10. Comparative accuracy of supine-only and combined supine-prone myocardial perfusion imaging in men.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2016
    Article
  11. Article
  12. Caffeine reduces the sensitivity of vasodilator MPI for the detection of myocardial ischaemia: Pro.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2016
    Article
  13. A second look with prone SPECT myocardial perfusion imaging reduces the need for angiography in patients at low risk for cardiac death or MI.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2015
    Article
  14. Article
  15. A multicenter evaluation of the appropriate use of single-photon emission tomography myocardial perfusion imaging in Greece.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2013
    Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Eliana ReyesNuclear Medicine Department, Royal Brompton Hospital, London, UK.
Susanna Wiener
S Richard Underwood
European Council of Nuclear Cardiology

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis is the second of a series of surveys designed to assess myocardial perfusion scintigraphy (MPS) practice in Europe.

methodsData were collected from 258 centres in 18 countries. The number of MPS studies per million population (pmp) was estimated assuming that the nonresponding centres performed either no studies (lower estimate) or the same number as the responding centres (upper estimate).

resultsThe responding centres served 24% of the population of their countries. The total number of noncardiac nuclear medicine studies was between 2,160 and 8,000 studies pmp. The total number of MPS studies was between 529 and 2,293 pmp. The median number of MPS studies per centre was 571 per year with 57% performing fewer than 500 studies per year and 23% of centres performing fewer than 250 studies per year. There was significant variation between countries, with higher numbers of MPS studies (lower limit of estimate above the mid-range of all countries combined) in Austria, Denmark, Hungary, Portugal and Slovenia, and lower numbers (upper limit of estimate below the mid-range of all countries) in Finland, Norway, Spain and Switzerland. The ratio of MPS to coronary angiography to revascularization procedures was 0.9 to 2.2 to 1. Pharmacological stress was used in 57% and technetium-99m-labelled tracers in 88% of studies. ECG gating was performed in 74% of studies and attenuation correction in 22%.

conclusionMPS utilization in Europe remains low compared with coronary angiography although there has been a 21% increase in the number of studies pmp in centres that reported in both 2005 and 2007. Pharmacological agents continue to be the predominant form of stress. Despite the widespread use of technetium-99m-labelled tracers, ECG gating is not universally performed. As in the 2005 survey, imaging aids such as attenuation and motion correction and prone imaging are not commonly used.

Indexed as

CardiologyNuclear MedicineSurveys and QuestionnairesEuropeMyocardial Perfusion ImagingStress, Physiological

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.